/ /

  • linkedin
  • Increase Font
  • Sharebar

    In the know: Toyota helps visually impaired go places

    A roundup of the latest news stories relating to ophthalmology

     

    Stephen From

    4. EyeGate Pharma acquires Jade Therapeutics

    With the acquisition, EyeGate will now have pre-clinical projects as well as Jade’s proprietary, cross-linked, bio-erodible hydrogel technology. “Our expanded pipeline now includes both preclinical and clinical assets that collectively address a large market opportunity,” said Stephen From, EyeGate chief executive officer.

    Jolie Higazi
    Jolie is the Content Specialist for Ophthalmology Times. She can be reached at jolie.higazi@advanstar.com.

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results